The class of drugs that neutralize the acid in the stomach are known as antacids. It is used to treat conditions like heartburn, indigestion, acidity and an upset stomach. These drugs are available over the counter and are usually consumed by mouth. They are available in tablets, capsules, liquid and powder form. There are different types of antacid available like aluminium hydroxide, magnesium carbonate, magnesium trisilicate, magnesium hydroxide, calcium carbonate, and sodium bicarbonate.
Sanofi, and GlaxoSmithKline plc. – Notable Market Players in Antacid Market
Market leaders operating in the market have undertaken various organic growth strategies in the antacid market. The antacid majorly consists of the players such as Sanofi, GlaxoSmithKline plc, Bayer AG, Takeda Pharmaceutical Company Limited, Sun Pharmaceuticals Ltd, Boehringer Ingelheim International Gmbh, Dr. Reddy’s Laboratories Ltd., Pfizer, Inc, Reckitt Benckiser Group Plc., and Procter And Gamble among others. Several organic approaches, such as product launches, and expansion in the Antacid, have resulted in the positive growth of the market. Product launches help the company to strengthen its product offering and the customer base, which allows the company to hold a strong position in the market. Similarly, utilizing expansion activities, it is easy to venture into untapped economies and use the opportunities being offered.
Below is the list of the growth strategies done by the players operating in the Antacid market:
| Year | News |
| Aug-20 | Takeda Pharmaceutical Company Limited declared that it has entered into an agreement to divest Takeda Consumer Healthcare Company Limited, a wholly-owned subsidiary of Takeda that operates in the consumer health care market primarily in Japan, to Oscar A-Co KK. This company is funded and managed by The Blackstone Group Inc. |
| Dec-2018 | GSK and Pfizer entered a joint venture for consumer healthcare businesses. This transaction created a new world-leading Consumer Healthcare. This transaction is expected to close within three years of the closing of the transaction. This venture is expected to help the companies to lead the product categories in the respective markets. The types include Pain Relief, Respiratory, Vitamin and Mineral Supplements, Digestive Health, Skin Health, and Therapeutic Oral Health. |
| Jun-2018 | GlaxoSmithKline plc acquired about 36.5% stake in its Consumer Healthcare from Novartis for an estimated value of about US$13 billion. This acquisition has helped the company to strengthen its Consumer Healthcare business worldwide. |
| May-2017 | Pfizer Limited (India) acquired AstraZeneca AB’s brand Neksium in India. The deal was valued at about Rs 75 crore. Neksium is an antacid that contains Esomeprazole as an API. |
| Jul-16 | Takeda Pharmaceutical Company Limited received FDA Approval for its antacid product Dexilant. It contains API dexlansoprazole. The product was approved for patients of age group of 12-17 Years. |
